Your University Signed First. Now Your Investor Wants To. Here’s What That Means

Most founders negotiate the valuation. Focus on everything else. One of the medtech ventures I currently advise is running a SAFE round. The regulatory sequencing is on track, they have a manufacturing LOI in place, and NIH and NSF applications are in review. By most measures, raising a Series A round is still a long […]

The 63-Year Clause: What One Term Sheet Taught Me About Structure

Why deep tech founders who resist structure don’t protect themselves, they just delay the reckoning Note: This piece was prompted by a real engagement. All details , such as geography, technology sector, deal terms, and financial figures, are illustrative. The structural pattern, however, is real and recurring. I was recently working with a founder who […]